BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 24705689)

  • 1. Involvement of substance P and the NK-1 receptor in human pathology.
    Muñoz M; Coveñas R
    Amino Acids; 2014 Jul; 46(7):1727-50. PubMed ID: 24705689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurokinin-1 receptor: a new promising target in the treatment of cancer.
    Muñoz M; Coveñas R
    Discov Med; 2010 Oct; 10(53):305-13. PubMed ID: 21034671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NK-1 receptor antagonists: a new paradigm in pharmacological therapy.
    Muñoz M; Coveñas R
    Curr Med Chem; 2011; 18(12):1820-31. PubMed ID: 21466470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do substance P and the NK1 receptor have a role in depression and anxiety?
    McLean S
    Curr Pharm Des; 2005; 11(12):1529-47. PubMed ID: 15892660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of substance P in the cardiovascular system.
    Mistrova E; Kruzliak P; Chottova Dvorakova M
    Neuropeptides; 2016 Aug; 58():41-51. PubMed ID: 26706184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of substance P and the NK-1 receptor in cancer progression.
    Muñoz M; Coveñas R
    Peptides; 2013 Oct; 48():1-9. PubMed ID: 23933301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substance P and neurokinin-1 receptor modulation of HIV.
    Ho WZ; Douglas SD
    J Neuroimmunol; 2004 Dec; 157(1-2):48-55. PubMed ID: 15579279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer progression and substance P.
    Coveñas R; Muñoz M
    Histol Histopathol; 2014 Jul; 29(7):881-90. PubMed ID: 24535838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The substance P/neurokinin-1 receptor system in lung cancer: focus on the antitumor action of neurokinin-1 receptor antagonists.
    Muñoz M; González-Ortega A; Rosso M; Robles-Frias MJ; Carranza A; Salinas-Martín MV; Coveñas R
    Peptides; 2012 Dec; 38(2):318-25. PubMed ID: 23026680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunolocalization of substance P and NK-1 receptor in Hofbauer cells in human normal placenta.
    Muñoz M; Carranza A; Pavón A; Anderson G; Coveñas R
    Microsc Res Tech; 2013 Dec; 76(12):1310-3. PubMed ID: 24155270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of substance P and the NK-1 receptor in pancreatic cancer.
    Muñoz M; Coveñas R
    World J Gastroenterol; 2014 Mar; 20(9):2321-34. PubMed ID: 24605029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The NK-1 receptor: a new target in cancer therapy.
    Muñoz M; Rosso M; Coveñas R
    Curr Drug Targets; 2011 Jun; 12(6):909-21. PubMed ID: 21226668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of neurokinin-1 receptor by substance P inhibits melanogenesis in B16-F10 melanoma cells.
    Ping F; Shang J; Zhou J; Song J; Zhang L
    Int J Biochem Cell Biol; 2012 Dec; 44(12):2342-8. PubMed ID: 23041339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human neuronal cells (NT2-N) express functional substance P and neurokinin-1 receptor coupled to MIP-1 beta expression.
    Li Y; Douglas SD; Pleasure DE; Lai J; Guo C; Bannerman P; Williams M; Ho W
    J Neurosci Res; 2003 Feb; 71(4):559-66. PubMed ID: 12548712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunolocalization of substance P and NK-1 receptor in vascular anomalies.
    Ortiz-Prieto A; Bernabeu-Wittel J; Zulueta-Dorado T; Lorente-Lavirgen AI; Muñoz M
    Arch Dermatol Res; 2017 Mar; 309(2):97-102. PubMed ID: 27988892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurobiology of substance P and the NK1 receptor.
    Mantyh PW
    J Clin Psychiatry; 2002; 63 Suppl 11():6-10. PubMed ID: 12562137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Roles of substance P and NK(1) receptor in the brainstem in the development of emesis.
    Saito R; Takano Y; Kamiya HO
    J Pharmacol Sci; 2003 Feb; 91(2):87-94. PubMed ID: 12686752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of substance P in inflammatory disease.
    O'Connor TM; O'Connell J; O'Brien DI; Goode T; Bredin CP; Shanahan F
    J Cell Physiol; 2004 Nov; 201(2):167-80. PubMed ID: 15334652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NK-1 receptor antagonists as antitumor drugs: a survey of the literature from 2000 to 2011.
    Muñoz M; Martinez-Armesto J; Coveñas R
    Expert Opin Ther Pat; 2012 Jul; 22(7):735-46. PubMed ID: 22697287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunolocalization of Substance P and NK-1 Receptor in ADIPOSE Stem Cells.
    Muñoz M; Muñoz MF; Ayala A
    J Cell Biochem; 2017 Dec; 118(12):4686-4696. PubMed ID: 28500728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.